High non-specific T lymphocyte response to the adjuvanted H1N1 vaccine in comparison with the H1N1/H3N2/B-Brisbane vaccine without adjuvant. (Q30420042)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22862739%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

High non-specific T lymphocyte response to the adjuvanted H1N1 vaccine in comparison with the H1N1/H3N2/B-Brisbane vaccine without adjuvant (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22862739%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22862739%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

M Petrovec

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22862739%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

M Lainščscak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22862739%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

P Meško

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22862739%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

M Silar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22862739%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

M Košnik

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22862739%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

1 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22862739%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Immunology

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22862739%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22862739%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22862739%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

497-504

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22862739%20AND%20SRC:MED&resulttype=core&format=json

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02763.X

Response to a monovalent 2009 influenza A (H1N1) vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02763.X

Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02763.X

Safety and effectiveness of a 2009 H1N1 vaccine in Beijing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02763.X

A novel influenza A (H1N1) vaccine in various age groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02763.X

Viral connection between drug rashes and autoimmune diseases: how autoimmune responses are generated after resolution of drug rashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02763.X

Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02763.X

Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02763.X

Autoimmune response following annual influenza vaccination in 92 apparently healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02763.X

Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix]: a review of its use as an active immunization against influenza A subtype H5N1 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02763.X

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02763.X

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02763.X